Seeking Alpha
Profile| Send Message| ()  
All of the following companies have recently reported insider buying. The fact that insiders are buying these names could be a good sign that there is significant upside potential in these shares. I have provided links for each stock which verifies the insider buying filed with the SEC below. Here are the five stocks:
Aastrom Biosciences, Inc. (ASTM) is trading around $2.30. Aastrom is a biotechnology company, based in Michigan. The 50-day moving average is $2.43 and the 200-day moving average is $2.10. These shares have traded in a range between $1.32 to $4.45 in the last 52 weeks. There have been multiple insiders buying, including the CEO and CFO, with the most recent purchase being a director who bought 20,000 shares. You can see the repeated insider buying here.

What Aastrom insiders and other investors might be seeing: The balance sheet is strong with basically no debt and plenty of cash. According to Yahoo Finance, ASTM has about $31 million in cash on the balance sheet. On March 28, an analyst at Stifel Nicolaus upgraded the shares to a buy, which you can see here.

Xoma, Ltd. (XOMA) shares are trading at $4.60. XOMA is a biotech company. The 50-day moving average is $4.86 and the 200-day moving average is $4.15. These shares have traded in a range between $2.24 to $12.60 in the last 52 weeks. You can see the insider buying here.

What Xoma insiders and others might be seeing: Shares in XOMA recently plunged from about $4.60 to under $3, so insiders might be trying to do some bargain hunting. The shares dropped on disappointing news with their diabetes drug, which you can read about here. I am not a fan of XOMA shares and I even suggested it might be smart to sell the shares when they were over $4.60 in this article. But, at some point, this might make a good bounce trade since the shares are oversold. Earnings estimates at XOMA indicate a loss for 2011.

Presidential Life Corporation (PLFE) is trading at $9.30. Presidential Life is based in New York and sells annuities, life insurance and other related products. These shares have a 52-week range of $8.34 and $12.37. The 50-day moving average is $9.50 and the 200-day moving average is $9.49, so the shares are trading near these key support levels. Earnings estimates for PLFE are not available. Book value is stated at $24.57 per share. You can see the repeated insider buying here.

What Presidential Life insiders and other investors might be seeing: Presidential just reported a strong quarter. For the full year of 2010, Presidential Life had net income of $21.5 million or 73 cents per share, compared with net income of $14.7 million 50 cents per share for the full year of 2009. With these shares trading significantly below book and earnings growth, they appear to offer value. You can read the full press release on earnings here.

Opko Health Inc., (OPK) is trading around $3.71. Opko is a specialty drug and vaccine company, based in Florida. These shares have traded in a range between $1.80 to $5.03 in the last 52 weeks. The 50-day moving average is $4.05 and the 200-day moving average is $3.07. OPK is estimated to post a loss in 2011. You can see the repeated insider buying here.

What Opko insiders and other investors might be seeing: This company has some interesting products like retina tracking and others relating to ophthalmology, which could have significant potential. It just raised capital to fund additional research and product development. This capital raise brought the share price down, so some investors are taking advantage of the lower prices. You can learn more about its products here.

Heckmann Corporation (HEK) is trading around $6.57. Heckmann is an investment company, and is based in California. These shares have traded in a range between $3.63 to $6.72 in the last 52 weeks. The 50-day moving average is $5.60 and the 200-day moving average is $4.68. HEK is estimated to earn about 16 cents per share in 2011 and 26 cents for 2012. You can see the insider buying here.

What Heckmann insiders and other investors might be seeing: The book value is stated at $2.64 and the company has a strong balance sheet. According to Yahoo Finance, HEK as about $178 million in cash. This should give it plenty of funds to find future investments.

The data is sourced from Yahoo Finance and Insidercow.com. The information and data is believed to be accurate, but no guarantees or representations are made. Rougemont is not a registered investment advisor and does not provide specific investment advice. The information contained herein is for informational purposes.

Source: 5 Stocks Under $10 With New Insider Buying